MaxCyte launches Expert cell engineering products

By The Science Advisory Board staff writers

June 25, 2020 -- Cell-based medicines and life sciences company MaxCyte has launched a new line of disposable cell engineering products.

The Expert line of disposables was created in response to customer feedback requesting new processing volumes for growing fields, such as cellular therapy and gene editing. The first product in the line is the R-100 curvette, which can process up to 1 milliliter or 200 million cells.

The R-100 curvette can be used with MaxCyte's electroporation instrumentation, including the Expert Atx, Stx, and Gtx. It was designed for use by companies developing cell therapy drugs or working in early drug discovery, according to the company.

Caribou, MaxCyte enter CRISPR license agreement
Caribou Biosciences and MaxCyte have announced a clinical and commercial license agreement for the development of Carbiou's CAR-T cell therapy program.
Extractables and Leachables in Single-Use Bioprocessing
At The Science Advisory Board ®, we recognize the important role that bioprocessing and drug development scientists play in the biopharmaceutical industry,...
The Future is Here... Applications of 3D Printing in Biopharmaceuticals
There’s some seriously cool science being developed with the help of 3D printing including transparent skulls to allow researchers to view real-time brain...
The Breakthrough World of Bioprocessing
Biomanufacturing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion...
Overlooked benefits of using polyclonal antibodies
The benefits of polyclonal antibodies as tools for assay-specific target discovery and detection are numerous. As the future of basic research, diagnostics...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter